Scientists hunt for blood clues to spot diabetic nerve pain early

NCT ID NCT07518433

Not yet recruiting Knowledge-focused Sponsor: Zhejiang Chinese Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will analyze blood samples from 90 people — 30 healthy, 30 with diabetes but no nerve issues, and 30 with diabetic peripheral neuropathy (nerve damage causing pain). Researchers will look for unique molecules in the blood that could serve as early warning signs. The goal is to improve diagnosis and understand the disease better, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to detect diabetic nerve damage earlier, and point toward new treatment targets.
What could go wrong: This is an early observational study with only 90 participants, so results may not apply to everyone. It looks for markers, not a treatment, so direct patient benefit is not immediate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHY (DPN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy diabetic polyneuropathy Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC PERIPHERAL NEUROPATHY (DPN) PAIN

Contacts and locations

Locations

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, 310053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.